Diabetes Drugs May Raise Thyroid Cancer Risk in 1st Year, Researchers Note Study Limitations

A recent study indicates that diabetes medications like Ozempic and Rybelsus may be linked to increased risk of thyroid cancer.

KK Stock/Shutterstock

A study published in JAMA Otolaryngology Head & Neck Surgery suggests a possible link between thyroid cancer and diabetes drugs such as Ozempic and Rybelsus, especially in the first year of use.

The study, involving 351,913 adults with Type 2 diabetes, examined those treated with GLP-1RAs, the class of drugs that includes Rybelsus and Ozempic, compared to patients treated with other glucose-lowering diabetes medications.